Results 91 to 100 of about 16,340 (253)

Temporary Reversal of Hepatoenteric Collaterals during ⁹⁰Y Radioembolization Planning and Administration

Current Oncology, 2022
Purpose: This paper aims to evaluate the safety and efficacy of the temporary redirection of blood flow of hepatoenteric collaterals using a balloon catheter in the common hepatic artery (CHA) to prevent the nontarget deposition of 90Y microspheres ...
Peiman Habibollahi, Bruno C. Odisio, Varshana Gurusamy, Joshua D. Kuban, Rony Avritscher, Mohamed E. Abdelsalam, Beth A. Chasen, Ravi Murthy, Armeen Mahvash   +8 more
doaj   +1 more source

Transarterial Radioembolization Versus Atezolizumab–Bevacizumab in Unresectable Hepatocellular Carcinoma: A Matching-Adjusted Indirect Comparison of Time to Deterioration in Quality of Life

Advances in Therapy, 2022
Given the relatively short life expectancy of patients with hepatocellular carcinoma (HCC), quality of life (QOL) plays a significant role in treatment selection.
I. Agirrezabal, V. Brennan, F. Colaone, S. Shergill, H. Pereira, G. Chatellier, V. Vilgrain   +6 more
semanticscholar   +1 more source

Advancements in Targeted Radiopharmaceuticals: Innovations in Diagnosis and Therapy for Enhanced Cancer Management

ChemBioChem, Volume 27, Issue 1, January 2026.
Radiopharmaceuticals enable precise cancer diagnosis and targeted therapy by combining radioactive isotopes with carrier molecules. This review summarizes advances from 2014 to 2025, emphasizing probe design, click chemistry, novel targets, and nanodelivery systems.
Mohd Sayeed Shaikh, Rupesh R. Kurhade, Abrar A. M. Siddiqui, Shaikh Shahbaz A. Majeed, Thomas J. Webster, Mohammad Intakhab Alam, Abdul Wasy Zia, Md. Faiyazuddin   +7 more
wiley   +1 more source

Efficacy and Safety of Transarterial Radioembolization in Elderly Patients with Hepatocellular Carcinoma: A Single-Center Experience

The Turkish Journal of Gastroenterology
Background/Aims: Hepatocellular carcinoma is a major cause of mortality and morbidity in both cirrhotic and non-cirrhotic patients, and most patients are suitable for locoregional and/or systemic therapy at the time of diagnosis.
Ümit Karaoğullarından, Yüksel Gümürdülü, Oğuz Üsküdar, Emre Odabaş, Hasan Selim Güler, Cansu Geçkalan, Burcu Aslan Benli, Anıl Delik , Asena Ayça Özdemir, Sedef Kuran   +9 more
doaj   +1 more source

On the impact of injection distance to bifurcations on yttrium-90 distribution in liver cancer radioembolization.

Journal of Vascular and Interventional Radiology, 2022
PURPOSE To evaluate the injection location effect on the distribution of yttrium-90 (90Y) microspheres in the liver during radioembolization and discuss the potential effects of radial movements of the catheter tip.
A. Taebi, Nursultan Janibek, R. Goldman, R. Pillai, C. Vu, E. Roncali   +5 more
semanticscholar   +1 more source

Emerging Role of MRI‐Based Artificial Intelligence in Individualized Treatment Strategies for Hepatocellular Carcinoma: A Narrative Review

Journal of Magnetic Resonance Imaging, Volume 63, Issue 1, Page 79-97, January 2026.
ABSTRACT Hepatocellular carcinoma (HCC) is the most common subtype of primary liver cancer, with significant variability in patient outcomes even within the same stage according to the Barcelona Clinic Liver Cancer staging system. Accurately predicting patient prognosis and potential treatment response prior to therapy initiation is crucial for ...
Feng Che, Jing Zhu, Qian Li, Hanyu Jiang, Yi Wei, Bin Song   +5 more
wiley   +1 more source

Transarterial therapy: An evolving treatment modality of hepatocellular carcinoma

The Saudi Journal of Gastroenterology, 2014
Liver cancer is the fifth most common cancer in men, the seventh most common in women, and the third most common cause of death from cancer worldwide.
Khalid A Jazieh, Mohammad Arabi, Azzam A Khankan   +2 more
doaj   +1 more source

Polyethylene Glycol Epirubicin-Loaded Transcatheter Arterial Chemoembolization Procedures Utilizing a Combined Approach with 100 and 200 μm Microspheres: A Promising Alternative to Current Standards [PDF]

, 2019
PURPOSE:To report clinical effectiveness, toxicity profile, and prognostic factors of combined 100 μm ± 25 and 200 μm ± 50 epirubicin-loaded polyethylene glycol (PEG) microsphere drug-eluting embolic transcatheter arterial chemoembolization protocol in ...
Argirò, Renato, Bezzi, M., Catalano, C, Corona, M, Corradini, Sg, Corsi, A, De Rubeis, G, Fiorentino, F, Lucatelli, Pierleone, Mennini, G, Nardis, Pg, Rocco, Bianca, Saba, Luca   +12 more
core   +1 more source

Hydrogel Microspheres for Biomedical Applications

Small Science, Volume 6, Issue 1, January 2026.
Hydrogel microspheres (HMs) play pivotal roles in biomedical applications, such as drug delivery, cell culture, regenerative medicine, wound healing, and tumor immunity. This review focuses on the latest findings to provide a more comprehensive understanding of HMs for biomedical applications.
Yingkang Huang, Xi Zhu, Jinhong Zhou, Henan Li, Wei Zhang, Danyang Shen, Ziyan Huang, Tianbo Zhang, Lin Zhuang, Lei Qin, Xiaofeng Xue, Yunjie Lu   +11 more
wiley   +1 more source

Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma.

Gastroenterology, 2016
BACKGROUND & AIMS Conventional transarterial chemoembolization (cTACE) is used to treat patients with hepatocellular carcinoma (HCC). Radioembolization is a minimally invasive procedure that involves implantation of radioactive micron-sized particles ...
R. Salem, A. Gordon, S. Mouli, R. Hickey, J. Kallini, A. Gabr, M. Mulcahy, Talia B. Baker, M. Abecassis, F. Miller, V. Yaghmai, Kent T. Sato, K. Desai, B. Thornburg, A. Benson, A. Rademaker, D. Ganger, L. Kulik, R. Lewandowski   +18 more
semanticscholar   +1 more source